We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Rishika Reddy has been assisting clients through the H1B Visa process since 2022.

As of 2022, Rishika Reddy has succesfully submitted and recieved certification for 1,428 cases.

Rishika Reddy is located in Richardson, TX, and has represented 2 employers for the H1B Visa Process

1,431
Cases Handled
1,428
Cases Certified
99.79%
Approval

Cases Handled by Rishika Reddy

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-24149-044432 Certified Graphic Designers Administrative Management And General Management Consulting Services Deloitte Consulting Llp 2024
I-200-24149-041715 Certified Graphic Designers Administrative Management And General Management Consulting Services Deloitte Consulting Llp 2024
I-200-23102-925024 Certified Graphic Designers Management Consulting Services Deloitte Consulting Llp 2023
I-200-22103-065097 Certified Graphic Designers Management Consulting Services Deloitte Consulting Llp 2022
I-200-24078-808572 Certified Commercial And Industrial Designers Administrative Management And General Management Consulting Services Deloitte Consulting Llp 2024
I-200-24150-046991 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Scribe Therapeutics Inc 2024
I-200-24138-009600 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Scribe Therapeutics Inc 2024
I-200-24116-927534 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Scribe Therapeutics Inc 2024
I-200-24113-913641 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Scribe Therapeutics Inc 2024
I-200-24143-023607 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Scribe Therapeutics Inc 2024